A detailed history of Nantahala Capital Management, LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 675,000 shares of ATXS stock, worth $7.64 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
675,000
Previous 675,000 -0.0%
Holding current value
$7.64 Million
Previous $6.14 Million -0.0%
% of portfolio
0.41%
Previous 0.41%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.83 - $13.51 $5.96 Million - $9.12 Million
675,000 New
675,000 $6.14 Million

Others Institutions Holding ATXS

About Astria Therapeutics, Inc.


  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $172M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.